Pegylated IFNs for chronic hepatitis C: an update

By Grace Michael J   Cutler David L   Bordens Ronald W  

Expert Opinion on Drug Delivery, Vol. 2, Iss. 2, 2005-03 ,pp. : 219-226

Informa Healthcare

Access to resources Recommend Favorite

PEGylated nanomedicines: recent progress and remaining concerns

By Vllasaliu Driton   Fowler Robyn   Stolnik Snow  

Expert Opinion on Drug Delivery, Vol. 11, Iss. 1, 2014-01 ,pp. : 139-154

Informa Healthcare

Access to resources Recommend Favorite

Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF

By Yatuv Rivka   Robinson Micah   Dayan Inbal   Baru Moshe  

Expert Opinion on Drug Delivery, Vol. 7, Iss. 2, 2010-02 ,pp. : 187-201

Informa Healthcare

Access to resources Recommend Favorite

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance

By Pennisi Manuela   Bertino Gaetano   Gagliano Caterina   Malaguarnera Michele   Bella Rita   Borzì Antonio Maria   Madeddu Roberto   Drago Filippo   Malaguarnera Giulia  

Nutrients, Vol. 9, Iss. 8, 2017-08 ,pp. : 897-897

MDPI

Access to resources Recommend Favorite

In vitro and in vivo evaluation of Assam Bora rice starch-based bioadhesive microsphere as a drug carrier for colon targeting

By Ahmad Mohammad Zaki   Akhter Sohail   Ahmad Iqbal   Singh Anjali   Anwar Mohammad   Shamim Mohammad   Ahmad Farhan Jalees  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 2, 2012-02 ,pp. : 141-149

Informa Healthcare

Access to resources Recommend Favorite